May 9 (Reuters) - Sygnis AG LIO1k.DE :
* Plans to acquire profitable proteomics player Expedeon
Holdings Ltd
* Combined 2016 pro-forma revenues to exceed 5 million euros
($5.7 million)
* Planned capital increase by way of a rights offering of up
to 20.5 million shares
* Expected proceeds of up to 5 million euros to cover
additional cash payment to expedeon shareholders and
transaction-related expenses
* New shares not subscribed will be offered to expedeon
shareholders as contribution in kind in exchange for expedeon
shares
Source text: http://bit.ly/1WjJZo0
Further company coverage: LIO1k.DE
($1 = 0.8769 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))